23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Severe trauma represents a major global public health burden and the management of post-traumatic bleeding continues to challenge healthcare systems around the world. Post-traumatic bleeding and associated traumatic coagulopathy remain leading causes of potentially preventable multiorgan failure and death if not diagnosed and managed in an appropriate and timely manner. This sixth edition of the European guideline on the management of major bleeding and coagulopathy following traumatic injury aims to advise clinicians who care for the bleeding trauma patient during the initial diagnostic and therapeutic phases of patient management.

          Methods

          The pan-European, multidisciplinary Task Force for Advanced Bleeding Care in Trauma included representatives from six European professional societies and convened to assess and update the previous version of this guideline using a structured, evidence-based consensus approach. Structured literature searches covered the period since the last edition of the guideline, but considered evidence cited previously. The format of this edition has been adjusted to reflect the trend towards concise guideline documents that cite only the highest-quality studies and most relevant literature rather than attempting to provide a comprehensive literature review to accompany each recommendation.

          Results

          This guideline comprises 39 clinical practice recommendations that follow an approximate temporal path for management of the bleeding trauma patient, with recommendations grouped behind key decision points. While approximately one-third of patients who have experienced severe trauma arrive in hospital in a coagulopathic state, a systematic diagnostic and therapeutic approach has been shown to reduce the number of preventable deaths attributable to traumatic injury.

          Conclusion

          A multidisciplinary approach and adherence to evidence-based guidelines are pillars of best practice in the management of severely injured trauma patients. Further improvement in outcomes will be achieved by optimising and standardising trauma care in line with the available evidence across Europe and beyond.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s13054-023-04327-7.

          Key messages

          • Immediate detection and management of traumatic coagulopathy improves outcomes of severely injured patients.

          • This guideline follows management of the severe trauma patient in chronological order, with a focus on prevention of possible exsanguination.

          • These structured recommendations support measures that prioritise the optimisation of resources for the benefit of bleeding control based on scientific evidence.

          • Empirical management should not be implemented unless no method of monitoring bleeding and coagulation is available.

          • Optimal organisation of the resuscitation team for the bleeding trauma patient includes implementation of these guidelines.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s13054-023-04327-7.

          Related collections

          Most cited references391

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

          Flaws in the design, conduct, analysis, and reporting of randomised trials can cause the effect of an intervention to be underestimated or overestimated. The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.

            Tranexamic acid can reduce bleeding in patients undergoing elective surgery. We assessed the effects of early administration of a short course of tranexamic acid on death, vascular occlusive events, and the receipt of blood transfusion in trauma patients. This randomised controlled trial was undertaken in 274 hospitals in 40 countries. 20 211 adult trauma patients with, or at risk of, significant bleeding were randomly assigned within 8 h of injury to either tranexamic acid (loading dose 1 g over 10 min then infusion of 1 g over 8 h) or matching placebo. Randomisation was balanced by centre, with an allocation sequence based on a block size of eight, generated with a computer random number generator. Both participants and study staff (site investigators and trial coordinating centre staff) were masked to treatment allocation. The primary outcome was death in hospital within 4 weeks of injury, and was described with the following categories: bleeding, vascular occlusion (myocardial infarction, stroke and pulmonary embolism), multiorgan failure, head injury, and other. All analyses were by intention to treat. This study is registered as ISRCTN86750102, Clinicaltrials.govNCT00375258, and South African Clinical Trial RegisterDOH-27-0607-1919. 10 096 patients were allocated to tranexamic acid and 10 115 to placebo, of whom 10 060 and 10 067, respectively, were analysed. All-cause mortality was significantly reduced with tranexamic acid (1463 [14.5%] tranexamic acid group vs 1613 [16.0%] placebo group; relative risk 0.91, 95% CI 0.85-0.97; p=0.0035). The risk of death due to bleeding was significantly reduced (489 [4.9%] vs 574 [5.7%]; relative risk 0.85, 95% CI 0.76-0.96; p=0.0077). Tranexamic acid safely reduced the risk of death in bleeding trauma patients in this study. On the basis of these results, tranexamic acid should be considered for use in bleeding trauma patients. UK NIHR Health Technology Assessment programme, Pfizer, BUPA Foundation, and J P Moulton Charitable Foundation. Copyright 2010 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition

              Background Severe traumatic injury continues to present challenges to healthcare systems around the world, and post-traumatic bleeding remains a leading cause of potentially preventable death among injured patients. Now in its fifth edition, this document aims to provide guidance on the management of major bleeding and coagulopathy following traumatic injury and encourages adaptation of the guiding principles described here to individual institutional circumstances and resources. Methods The pan-European, multidisciplinary Task Force for Advanced Bleeding Care in Trauma was founded in 2004, and the current author group included representatives of six relevant European professional societies. The group applied a structured, evidence-based consensus approach to address scientific queries that served as the basis for each recommendation and supporting rationale. Expert opinion and current clinical practice were also considered, particularly in areas in which randomised clinical trials have not or cannot be performed. Existing recommendations were re-examined and revised based on scientific evidence that has emerged since the previous edition and observed shifts in clinical practice. New recommendations were formulated to reflect current clinical concerns and areas in which new research data have been generated. Results Advances in our understanding of the pathophysiology of post-traumatic coagulopathy have supported improved management strategies, including evidence that early, individualised goal-directed treatment improves the outcome of severely injured patients. The overall organisation of the current guideline has been designed to reflect the clinical decision-making process along the patient pathway in an approximate temporal sequence. Recommendations are grouped behind the rationale for key decision points, which are patient- or problem-oriented rather than related to specific treatment modalities. While these recommendations provide guidance for the diagnosis and treatment of major bleeding and coagulopathy, emerging evidence supports the author group’s belief that the greatest outcome improvement can be achieved through education and the establishment of and adherence to local clinical management algorithms. Conclusions A multidisciplinary approach and adherence to evidence-based guidance are key to improving patient outcomes. If incorporated into local practice, these clinical practice guidelines have the potential to ensure a uniform standard of care across Europe and beyond and better outcomes for the severely bleeding trauma patient. Electronic supplementary material The online version of this article (10.1186/s13054-019-2347-3) contains supplementary material, which is available to authorized users.
                Bookmark

                Author and article information

                Contributors
                RRossaint@ukaachen.de
                arash.afshari@regionh.dk
                BouillonB@kliniken-koeln.de
                vladimir.cerny@kzcr.eu , cernyvla@fnhk.cz
                dcimpoiesu@yahoo.com
                nicola.curry@ouh.nhs.uk
                jacques.duranteau@aphp.fr
                1danielaf@gmail.com
                ogrottke@ukaachen.de
                larsgroenlykke@gmail.com
                harroisanatole@yahoo.fr
                Beverley.Hunt@gstt.nhs.uk
                alexander.kaserer@usz.ch
                radko.komadina@gmail.com
                mikkel.herold.madsen.02@regionh.dk
                marc.maegele@t-online.de
                lidiamoramiquel@gmail.com
                louis.riddez@telia.com
                romero_carolinasol@gva.es
                marc.samama@aphp.fr
                jlvincent@intensive.org
                sebastian.christoph.wiberg@regionh.dk
                donat.spahn@usz.ch
                Journal
                Crit Care
                Critical Care
                BioMed Central (London )
                1364-8535
                1466-609X
                1 March 2023
                1 March 2023
                2023
                : 27
                : 80
                Affiliations
                [1 ]GRID grid.1957.a, ISNI 0000 0001 0728 696X, Department of Anaesthesiology, University Hospital Aachen, , RWTH, Aachen University, ; Pauwelsstrasse 30, D-52074 Aachen, Germany
                [2 ]GRID grid.5254.6, ISNI 0000 0001 0674 042X, Department of Paediatric and Obstetric Anaesthesia, Rigshospitalet, , University of Copenhagen, ; Blegdamsvej 9, DK-2100 Copenhagen, Denmark
                [3 ]GRID grid.412581.b, ISNI 0000 0000 9024 6397, Department of Trauma and Orthopaedic Surgery, Cologne-Merheim Medical Centre (CMMC), , University of Witten/Herdecke, ; Ostmerheimer Strasse 200, D-51109 Cologne, Germany
                [4 ]GRID grid.424917.d, ISNI 0000 0001 1379 0994, Department of Anaesthesiology, Perioperative Medicine and Intensive Care, Masaryk Hospital, , J.E. Purkinje University, ; Socialni pece 3316/12A, CZ-40113 Usti nad Labem, Czech Republic
                [5 ]GRID grid.4491.8, ISNI 0000 0004 1937 116X, Department of Anaesthesiology and Intensive Care Medicine, , Charles University Faculty of Medicine, ; Simkova 870, CZ-50003 Hradec Králové, Czech Republic
                [6 ]GRID grid.411038.f, ISNI 0000 0001 0685 1605, Department of Emergency Medicine, Emergency County Hospital “Sf. Spiridon” Iasi, , University of Medicine and Pharmacy ”Grigore T. Popa” Iasi, ; Blvd. Independentei 1, RO-700111 Iasi, Romania
                [7 ]GRID grid.410556.3, ISNI 0000 0001 0440 1440, Oxford Haemophilia and Thrombosis Centre, Nuffield Orthopaedic Centre, , Oxford University Hospitals NHS Trust, ; Windmill Road, Oxford, OX3 7HE UK
                [8 ]GRID grid.4991.5, ISNI 0000 0004 1936 8948, Radcliffe Department of Medicine, , Oxford University, ; Oxford, UK
                [9 ]GRID grid.460789.4, ISNI 0000 0004 4910 6535, Department of Anesthesiology, Intensive Care and Perioperative Medicine, Assistance Publique Hôpitaux de Paris, , Paris Saclay University, ; 78 rue du Général Leclerc, F-94275 Le Kremlin-Bicêtre Cedex, France
                [10 ]GRID grid.8194.4, ISNI 0000 0000 9828 7548, Department of Cardiac Anaesthesia and Intensive Care, “Prof. Dr. C. C. Iliescu” Emergency Institute of Cardiovascular Diseases, , Carol Davila University of Medicine and Pharmacy, ; Sos Fundeni 256-258, RO-022328 Bucharest, Romania
                [11 ]GRID grid.5254.6, ISNI 0000 0001 0674 042X, Department of Thoracic Anaesthesiology, The Heart Centre, Rigshospitalet, , University of Copenhagen, ; Blegdamsvej 9, DK-2100 Copenhagen, Denmark
                [12 ]GRID grid.420545.2, ISNI 0000 0004 0489 3985, Thrombosis and Haemophilia Centre, , Guy’s and St Thomas’ NHS Foundation Trust, ; Westminster Bridge Road, London, SE1 7EH UK
                [13 ]GRID grid.412004.3, ISNI 0000 0004 0478 9977, Institute of Anaesthesiology, , University Hospital Zurich, ; Raemistrasse 100, CH-8091 Zurich, Switzerland
                [14 ]GRID grid.8954.0, ISNI 0000 0001 0721 6013, Department of Traumatology, General and Teaching Hospital Celje, Medical Faculty, , Ljubljana University, ; Oblakova ulica 5, SI-3000 Celje, Slovenia
                [15 ]GRID grid.412581.b, ISNI 0000 0000 9024 6397, Department of Trauma and Orthopaedic Surgery, Cologne-Merheim Medical Centre (CMMC), Institute for Research in Operative Medicine (IFOM), , University of Witten/Herdecke, ; Ostmerheimer Strasse 200, D-51109 Cologne, Germany
                [16 ]GRID grid.7080.f, ISNI 0000 0001 2296 0625, Department of Anaesthesiology, Intensive Care and Pain Clinic, Vall d’Hebron Trauma, Rehabilitation and Burns Hospital, , Autonomous University of Barcelona, ; Passeig de la Vall d’Hebron 119-129, ES-08035 Barcelona, Spain
                [17 ]GRID grid.24381.3c, ISNI 0000 0000 9241 5705, Department of Surgery and Trauma, , Karolinska University Hospital, ; S-171 76 Solna, Sweden
                [18 ]GRID grid.106023.6, ISNI 0000 0004 1770 977X, Department of Anaesthesia, Intensive Care and Pain Therapy, Consorcio Hospital General Universitario de Valencia, , Universidad Europea of Valencia Methodology Research Department, ; Avenida Tres Cruces 2, ES-46014 Valencia, Spain
                [19 ]Department of Anaesthesia, Intensive Care and Perioperative Medicine, GHU AP-HP Centre - Université Paris Cité - Cochin Hospital, 27 rue du Faubourg St. Jacques, F-75014 Paris, France
                [20 ]GRID grid.4989.c, ISNI 0000 0001 2348 0746, Department of Intensive Care, Erasme University Hospital, , Université Libre de Bruxelles, ; Route de Lennik 808, B-1070 Brussels, Belgium
                Article
                4327
                10.1186/s13054-023-04327-7
                9977110
                36859355
                5b313ce4-66e6-4961-baf0-e553cd46cad9
                © The Author(s) 2023

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 16 November 2022
                : 20 January 2023
                Categories
                Guidelines
                Custom metadata
                © The Author(s) 2023

                Emergency medicine & Trauma
                emergency medicine,trauma,traumatic coagulopathy,major bleeding,haemostasis,practice guideline,diagnostics,management

                Comments

                Comment on this article